These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 35860245)

  • 61. Visualized Analyses of Investigations Upon Mesenchymal Stem/stromal Cell-based Cytotherapy and Underlying Mechanisms for COVID-19 Associated ARDS.
    Aitong W; Leisheng Z; Hao Y
    Curr Stem Cell Res Ther; 2022; 17(1):2-12. PubMed ID: 34254927
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Clinical characteristics and day-90 outcomes of 4244 critically ill adults with COVID-19: a prospective cohort study.
    COVID-ICU Group on behalf of the REVA Network and the COVID-ICU Investigators
    Intensive Care Med; 2021 Jan; 47(1):60-73. PubMed ID: 33211135
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Effectiveness of Mesenchymal Stem Cell Therapy for COVID-19-Induced ARDS Patients: A Case Report.
    Kim K; Bae KS; Kim HS; Lee WY
    Medicina (Kaunas); 2022 Nov; 58(12):. PubMed ID: 36556900
    [No Abstract]   [Full Text] [Related]  

  • 64. Immunomodulatory and Anti-fibrotic Effects Following the Infusion of Umbilical Cord Mesenchymal Stromal Cells in a Critically Ill Patient With COVID-19 Presenting Lung Fibrosis: A Case Report.
    da Silva KN; Pinheiro PCG; Gobatto ALN; Passos RDH; Paredes BD; França LSA; Nonaka CKV; Barreto-Duarte B; Araújo-Pereira M; Tibúrcio R; Cruz FF; Martins GLS; Andrade BB; de Castro-Faria-Neto HC; Rocco PRM; Souza BSF
    Front Med (Lausanne); 2021; 8():767291. PubMed ID: 34869480
    [No Abstract]   [Full Text] [Related]  

  • 65. Effect of EARLY administration of DEXamethasone in patients with COVID-19 pneumonia without acute hypoxemic respiratory failure and risk of development of acute respiratory distress syndrome (EARLY-DEX COVID-19): study protocol for a randomized controlled trial.
    Franco-Moreno A; Acedo-Gutiérrez MS; Martín NL; Hernández-Blanco C; Rodríguez-Olleros C; Ibáñez-Estéllez F; Suárez-Simón A; Balado-Rico M; Romero-Paternina AR; Alonso-Menchén D; Escolano-Fernández B; Piniella-Ruiz E; Alonso-Monge E; Notario-Leo H; Bibiano-Guillén C; Peña-Lillo G; Antiqueira-Pérez A; Romero-Pareja R; Cabello-Clotet N; Estrada-Pérez V; Troya-García J; de Carranza-López M; Escobar-Rodríguez I; Vallejo-Maroto N; Torres-Macho J
    Trials; 2022 Sep; 23(1):784. PubMed ID: 36109825
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Mesenchymal stromal cells to fight SARS-CoV-2: Taking advantage of a pleiotropic therapy.
    Barros I; Silva A; de Almeida LP; Miranda CO
    Cytokine Growth Factor Rev; 2021 Apr; 58():114-133. PubMed ID: 33397585
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Specific Clinical and Immunological Changes Following Mesenchymal Stem Cell Transplantation in COVID-19-induced Acute Respiratory Distress Syndrome Patients: A Phase-I Clinical Trial.
    Kaffash Farkhad N; Sedaghat A; Reihani H; Adhami Moghadam A; Bagheri Moghadam A; Khadem Ghaebi N; Khodadoust MA; Nikpoor AR; Tavakol Afshari J
    Iran J Allergy Asthma Immunol; 2022 Dec; 21(6):687-703. PubMed ID: 36640060
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Mesenchymal stromal cells as a therapeutic intervention for COVID-19: a living systematic review and meta-analysis protocol.
    Kirkham AM; Monaghan M; Bailey AJM; Shorr R; Lalu MM; Fergusson DA; Allan DS
    Syst Rev; 2021 Sep; 10(1):249. PubMed ID: 34526123
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Mesenchymal stem/stromal cell-based therapies for COVID-19: First iteration of a living systematic review and meta-analysis: MSCs and COVID-19.
    Kirkham AM; Monaghan M; Bailey AJM; Shorr R; Lalu MM; Fergusson DA; Allan DS
    Cytotherapy; 2022 Jun; 24(6):639-649. PubMed ID: 35219584
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The Use of High-Dose Corticosteroids Versus Low-Dose Corticosteroids With and Without Tocilizumab in COVID-19 Acute Respiratory Distress Syndrome.
    Katz A; Altshuler D; Papadopoulos J; Amoroso N; Goldenberg R; Tarras E; Krolikowski K; Hagedorn J; Fridman D; Chen XJC; Iturrate E; Brosnahan SB
    Ann Pharmacother; 2023 Jan; 57(1):5-15. PubMed ID: 35590468
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Review of Trials Currently Testing Stem Cells for Treatment of Respiratory Diseases: Facts Known to Date and Possible Applications to COVID-19.
    Majolo F; da Silva GL; Vieira L; Timmers LFSM; Laufer S; Goettert MI
    Stem Cell Rev Rep; 2021 Feb; 17(1):44-55. PubMed ID: 32827081
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Extracorporeal membrane oxygenation for COVID-19 and influenza H1N1 associated acute respiratory distress syndrome: a multicenter retrospective cohort study.
    Fanelli V; Giani M; Grasselli G; Mojoli F; Martucci G; Grazioli L; Alessandri F; Mongodi S; Sales G; Montrucchio G; Pizzi C; Richiardi L; Lorini L; Arcadipane A; Pesenti A; Foti G; Patroniti N; Brazzi L; Ranieri V
    Crit Care; 2022 Feb; 26(1):34. PubMed ID: 35123562
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Combined Mesenchymal Stromal Cell Therapy and Extracorporeal Membrane Oxygenation in Acute Respiratory Distress Syndrome. A Randomized Controlled Trial in Sheep.
    Millar JE; Bartnikowski N; Passmore MR; Obonyo NG; Malfertheiner MV; von Bahr V; Redd MA; See Hoe L; Ki KK; Pedersen S; Boyle AJ; Baillie JK; Shekar K; Palpant N; Suen JY; Matthay MA; McAuley DF; Fraser JF
    Am J Respir Crit Care Med; 2020 Aug; 202(3):383-392. PubMed ID: 32293914
    [No Abstract]   [Full Text] [Related]  

  • 74. Intra-articular injection of two different doses of autologous bone marrow mesenchymal stem cells versus hyaluronic acid in the treatment of knee osteoarthritis: multicenter randomized controlled clinical trial (phase I/II).
    Lamo-Espinosa JM; Mora G; Blanco JF; Granero-Moltó F; Nuñez-Córdoba JM; Sánchez-Echenique C; Bondía JM; Aquerreta JD; Andreu EJ; Ornilla E; Villarón EM; Valentí-Azcárate A; Sánchez-Guijo F; Del Cañizo MC; Valentí-Nin JR; Prósper F
    J Transl Med; 2016 Aug; 14(1):246. PubMed ID: 27565858
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Clinical progress in MSC-based therapies for the management of severe COVID-19.
    Rossello-Gelabert M; Gonzalez-Pujana A; Igartua M; Santos-Vizcaino E; Hernandez RM
    Cytokine Growth Factor Rev; 2022 Dec; 68():25-36. PubMed ID: 35843774
    [TBL] [Abstract][Full Text] [Related]  

  • 76. High- Versus Low-Dose Dexamethasone for the Treatment of COVID-19-Related Acute Respiratory Distress Syndrome: A Multicenter, Randomized Open-Label Clinical Trial.
    Maskin LP; Bonelli I; Olarte GL; Palizas F; Velo AE; Lurbet MF; Lovazzano P; Kotsias S; Attie S; Lopez Saubidet I; Baredes ND; Setten M; Rodriguez PO
    J Intensive Care Med; 2022 Apr; 37(4):491-499. PubMed ID: 34898320
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Safety and efficacy of antiviral combination therapy in symptomatic patients of Covid-19 infection - a randomised controlled trial (SEV-COVID Trial): A structured summary of a study protocol for a randomized controlled trial.
    Panda PK; Bandyopadhyay A; Singh BC; Moirangthem B; Chikara G; Saha S; Bahurupi YA
    Trials; 2020 Oct; 21(1):866. PubMed ID: 33081849
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Mesenchymal Stem Cells in the Treatment of COVID-19.
    Guo BC; Wu KH; Chen CY; Lin WY; Chang YJ; Lee TA; Lin MJ; Wu HP
    Int J Mol Sci; 2023 Sep; 24(19):. PubMed ID: 37834246
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Apoptotic cells for treatment of acute respiratory distress syndrome associated with COVID-19.
    van Heerden PV; Abutbul A; Naama A; Maayan S; Makram N; Nachshon A; Abu Jabal K; Hershkovitz O; Binder L; Shabat Y; Reicher B; Mevorach D
    Front Immunol; 2023; 14():1242551. PubMed ID: 37600829
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Effect of early administration of dexamethasone in patients with COVID-19 pneumonia without acute hypoxemic respiratory failure and risk of development of acute respiratory distress syndrome: EARLY-DEX COVID-19 trial.
    Franco-Moreno A; Acedo-Gutiérrez MS; Casado-Suela MÁ; Labrador-San Martín N; de Carranza-López M; Ibáñez-Estéllez F; Hernández-Blanco C; Jiménez-Torres J; Vallejo-Maroto I; Romero-Pareja R; Peña-Lillo G; Escobar-Rodríguez I; Torres-Macho J;
    Front Med (Lausanne); 2024; 11():1385833. PubMed ID: 39086948
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.